Acetylcholinesterase-Aβ complexes are more toxic than Aβ fibrils in rat hippocampus: Effect on rat β-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss

American Journal of Pathology

Volumn 164, Issue 6, 2004, Pages 2163-2174

  Reyes, Ariel E ^a,b   Chacón, Marcelo A ^a   Dinamarca, Margarita C ^a   Cerpa, Waldo ^a   Morgan, Carlos ^a,c   Inestrosa, Nibaldo C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DIEGO PORTALES   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ACETYLCHOLINESTERASE ABETA; AMYLOID BETA PROTEIN; CONGO RED; GLIAL FIBRILLARY ACIDIC PROTEIN; LAMININ; UNCLASSIFIED DRUG; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL LOSS; CONTROLLED STUDY; DEGENERATIVE DISEASE; ELECTRON MICROSCOPY; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; RAT; TURBIDITY; ANIMAL; CATTLE; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; GLIOSIS; HUMAN; IMAGE PROCESSING; PATHOLOGY; SPECTROFLUOROMETRY; SPRAGUE DAWLEY RAT;

ACETYLCHOLINESTERASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASTROCYTES; CATTLE; CELL SURVIVAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LAMININ; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, FLUORESCENCE;

EID: 2442647903     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63774-1     Document Type: Article

References (59)

1. Salmon DP, Bondi MW: Neuropsychology of Alzheimer disease. Alzheimer Disease. Edited by RD Terry, R Katzman, KL Bick, SS Sisodia. Philadelphia, Lippincott Williams & Wilkins, 1999, pp 39-56
2. Glenner GG: The pathobiology of Alzheimer's disease. Annu Rev Med 1989, 40:45-51
3. Selkoe DJ: Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001, 81:741-766
4. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D: Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989, 24:173-182
5. Selkoe DJ: The molecular pathology of Alzheimer's disease. Neuron 1991, 6:487-498
6. Roher A, Wolfe D, Palutke M, KuKuruga D: Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci USA 1986, 83:2662-2666
7. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K: Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991, 541:163-166
8. Abraham CR, Selkoe DJ, Potter H: Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of the Alzheimer's disease. Cell 1988, 52:487-501
9. Kalaria RN, Kroon SN, Grahovac I, Perry G: Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease. Neuroscience 1992, 51:177-184
10. Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K: Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am J Pathol 1994, 144:337-347
11. Liesi P, Kaakkola S, Dahl D, Vaheri A: Laminin is induced in astrocytes of adult brain by injury. EMBO J 1984, 3:683-686
12. Geula C, Mesulam M: Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res 1989, 498:185-189
13. Ulrich J, Meier-Ruge W, Probst A, Meier E, Ipsen S: Senile plaques: staining for acetylcholinesterase and A4 protein. A comparative study in the hippocampus and entorhinal cortex. Acta Neuropathol 1990, 80:624-628
14. Kasa P, Rakonczay Z, Gulya K: The cholinergic system in Alzheimer's disease. Prog Neurobiol 1997, 52:511-535
15. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR: Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982, 215:1237-1239
16. Talesa VN: Acetylcholinesterase in Alzheimer's disease. Mech Ageing Dev 2001, 122:1961-1969
17. Arendt T, Bigl V, Tennesdt A, Arendt A: Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience 1985, 14:1-14
18. Beeri R, Andres C, Lev-Lehman E, Timberg R, Huberman T, Shani M, Soreq H: Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice. Curr Biol 1995, 5:1063-1071
19. Beeri R, Le Novere N, Mervis R, Huberman T, Grauer E, Changeux JP, Soreq H: Enhanced hemicholinium binding and attenuated dendrite branching in cognitively impaired acetylcholinesterase-transgenic mice. J Neurochem 1997, 69:2441-2451
20. Sternfeld M, Shoham S, Klein O, Flores-Flores C, Evron T, Idelson GH, Kitsberg D, Patrick JW, Soreq H: Excess "read-through" acetylcholinesterase attenuates but the "synaptic" variant intensifies neurodeterioration correlates. Proc Natl Acad Sci USA 2000, 97:8647-8652
21. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J: Acetylcholinesterase accelerates assembly of amyloid-β-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 1996, 16:881-891
22. De Ferrari GV, Canales MA, Shin I, Weiner LM, Silman I, Inestrosa NC: A structural motif of acetylcholinesterase that promotes amyloid β-peptide fibril formation. Biochemistry 2001, 40:10447-10457
23. Alvarez A, Opazo C, Alarcón R, Garrido J, Inestrosa NC: Acetylcholinesterase promotes the aggregation of amyloid-β-peptide fragments by forming a complex with the growing fibrils. J Mol Biol 1997, 272:348-361
24. Alvarez A, Alarcon R, Opazo C, Campos EO, Muñoz FJ, Calderón FH, Dajas F, Gentry MK, Doctor BP, De Mello FG, Inestrosa NC: Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J Neurosci 1998, 18:3213-3223
25. Muñoz FJ, Inestrosa NC: Neurotoxicily of acetylcholinesterase-amyloid β-peptide aggregates is dependent on the type of Aβ peptide and the AChE concentration present in the complexes. FEBS Lett 1999, 450:205-209
26. Muñoz FJ, Opazo C, Gil-Gómez G, Tapia G, Fernández V, Valverde MA, Inestrosa NC: Vitamin E but not 17β-estradiol protect against vascular toxicity induced by β-amyloid wild-type and the Dutch amyloid variant. J Neurosci 2002, 22:3081-3089
27. Inestrosa NC, Roberts WL, Marshall TL, Rosenberry TL: Acetylcholinesterase from bovine caudate nucleus is attached to membranes by a novel subunit distinct from those of acetylcholinesterases in other tissues. J Biol Chem 1987, 262:4441-4444
28. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685
29. Ellman GK, Courtney KD, Andress V, Featherstone RM: A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961, 1:88-95
30. Klunk WE, Pettegrew JW, Abraham DJ: Quantitative evaluation of Congo red binding to amyloid-like proteins with a β-pleated sheet conformation. J Histochem Cytochem 1989, 37:1273-1281
31. Schagger H, von Jagow G: Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987, 166:368-379
32. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 2. New York, Academic Press, 1986
33. Côté SL, Ribeiro-Da-Silva A, Cuello AC: Immunocytochemistry II. Edited by AC Cuello. New York, John Wiley & Sons, 1993
34. Elghetany MT, Saleem A: Methods for staining amyloid in tissues: a review. Stain Technol 1988, 63:201-212
35. Puchtler H, Sweat F, Levine M: On the binding of Congo red by amyloid. J Histochem Cytochem 1961, 10:355-364
36. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SH: Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol 1988, 132:86-101
37. Dickson DW: The pathogenesis of senile plaques. J Neuropathol Exp Neurol 1997, 56:321-339
38. Glenner GG, Deanes ED, Page DL: The relation of the properties of Congo red-stained amyloid fibrils to the conformation. J Histochem Cytochem 1972, 20:821-826
39. Snow AD, Sekiguchi R, Nochlin D, Fraser P, Kimata K, Mizutani A, Arai M, Schreier WA, Morgan DG: An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A β-amyloid in rat brain. Neuron 1994, 12:219-234
40. Luckenbill-Edds L: Laminin and the mechanism of neuronal outgrowth. Brain Res Brain Res Rev 1997, 23:1-27
41. Murtomaki S, Risteli J, Risteli L, Koivisto UM, Johansson S, Liesi P: Laminin and its neurite outgrowth-promoting domain in the brain in Alzheimer's disease and Down's syndrome patients. J Neurosci Res 1992, 32:261-273
42. Morgan C, Garrido J: Laminin dissaggregates amyloid β-fibrils. Neurobiol Aging 1998, 19:S45
43. Morgan C, Inestrosa NC: Interactions of laminin with the amyloid β peptide. Implications for Alzheimer's disease. Braz J Med Biol Res 2001, 34:597-601
44. Morgan C, Bugueño MP, Garrido J, Inestrosa NC: Laminin affects polymerization, depolymerization and neurotoxicity of amyloid-β peptide. Peptides 2002, 23:1229-1240
45. Pike CJ, Cummings BJ, Cotman CW: Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp Neurol 1995, 132:172-179
46. Sigurdsson EM, Lee JM, Dong XW, Hejna MJ, Lorens SA: Bilateral injections of amyloid-β 25-35 into the amygdala of young Fischer rats: behavioral, neurochemical, time dependent histopathological effects. Neurobiol Aging 1997, 18:591-608
47. Soto C, Brañes MC, Alvarez J, Inestrosa NC: Structural determinants of the Alzheimer's amyloid β-peptide. J Neurochem 1994, 63:1191-1198
48. Bronfman FC, Garrido J, Alvarez A, Morgan C, Inestrosa NC: Laminin inhibits amyloid-β-peptide fibrillation. Neurosci Lett 1996, 218:201-203
49. Bronfman FC, Alvarez A, Morgan C, Inestrosa NC: Laminin blocks the assembly of wild-type Aβ and the Dutch variant peptide into Alzheimer's fibrils. Amyloid 1998, 5:16-23
50. Monji A, Tashiro K, Yoshida I, Hayashi Y, Tashiro N: Laminin inhibits Aβ 40 fibril formation promoted by apolipoprotein E4 in vitro. Brain Res 1998, 796:171-175
51. Frautschy SA, Baird A, Cole GM: Effects of Alzheimer β-amyloid cores in rat brain. Proc Natl Acad Sci USA 1991, 88:8362-8366
52. Inestrosa NC, Reyes AE: Acetylcholinesterase induces amyloid formation and increases neurotoxicity of Alzheimer's fibrils. Neurobiol Aging 1998, 19:S44
53. Reyes AE: Characterization of New Animal Models for the Study of Alzheimer's Disease. Ph.D. thesis. Pontifical Catholic University of Chile, 2000
54. Chacón MA, Reyes AE, Inestrosa NC: Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus. J Neurochem 87:195-204
55. Waite J, Cole GM, Frautschy SA, Connor DJ, Thal LJ: Solvent effects on β protein toxicity in vivo. Neurobiol Aging 1992, 13:595-599
56. Abe E, Casamenti F, Giovannelli L, Scali C, Pepeu G: Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res 1994, 636:162-164
57. Emre M, Geula C, Ransil BJ, Mesulam MM: The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain. Neurobiol Aging 1992, 13:553-559
58. Harkany T, Lengyel Z, Soos K, Penke B, Luiten PG, Gulya K: Cholinotoxic effects of β-amyloid (1-42) peptide on cortical projections of the rat nucleus basalis magnocellularis. Brain Res 1995, 695:71-75
59. Rees T, Hammond PI, Soreq H, Younkin S, Brimijoin S: Acetylcholinesterase promotes β-amyloid plaques in cerebral cortex. Neurobiol Aging 2003, 24:777-787